Unum Therapeutics, Inc. reported raising $65 Million in an initial SEC Form D filing, from an offering of $65 Million
PUBLIC · COGTJun 25, 2015
Amount Raised
$65 Million
$65 Million sold, per SEC Form D (first sale Jun 25, 2015)
Round Type
Venture
MassachusettsBiotechnologyWho to call at Cogent Biosciences, Inc., and when
A new round usually means Cogent Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cogent Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cogent Biosciences, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cogent Biosciences, Inc.. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cogent Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Cogent Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.